Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1978 1
1979 1
1981 3
1985 1
1989 3
1990 1
1993 1
1997 1
2001 3
2002 4
2003 3
2004 4
2005 11
2006 6
2007 6
2008 5
2009 14
2010 6
2011 8
2012 8
2013 9
2014 4
2015 4
2016 7
2017 2
2018 2
2019 2
2020 1
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
siRNA vs. shRNA: similarities and differences.
Rao DD, Vorhies JS, Senzer N, Nemunaitis J. Rao DD, et al. Among authors: senzer n. Adv Drug Deliv Rev. 2009 Jul 25;61(9):746-59. doi: 10.1016/j.addr.2009.04.004. Epub 2009 Apr 20. Adv Drug Deliv Rev. 2009. PMID: 19389436 Review.
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, Middleton MR, Miller WH Jr, Zager JS, Ye Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS. Andtbacka RH, et al. Among authors: senzer n. J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014293 Clinical Trial.
RNA interference and cancer therapy.
Wang Z, Rao DD, Senzer N, Nemunaitis J. Wang Z, et al. Among authors: senzer n. Pharm Res. 2011 Dec;28(12):2983-95. doi: 10.1007/s11095-011-0604-5. Epub 2011 Oct 19. Pharm Res. 2011. PMID: 22009588 Review.
Chemo-inducible gene therapy.
Mezhir JJ, Schmidt H, Yamini B, Senzer NN, Posner MC, Kufe DW, Weichselbaum RR. Mezhir JJ, et al. Among authors: senzer nn. Anticancer Drugs. 2005 Nov;16(10):1053-8. doi: 10.1097/00001813-200511000-00003. Anticancer Drugs. 2005. PMID: 16222146 Review.
RNA interference and personalized cancer therapy.
Rao DD, Wang Z, Senzer N, Nemunaitis J. Rao DD, et al. Among authors: senzer n. Discov Med. 2013 Feb;15(81):101-10. Discov Med. 2013. PMID: 23449112 Free article. Review.
Tumor vaccines and cellular immunotherapies.
Nemunaitis J, Senzer N, Plato L. Nemunaitis J, et al. Among authors: senzer n. Ann Transl Med. 2016 Oct;4(Suppl 1):S24. doi: 10.21037/atm.2016.10.54. Ann Transl Med. 2016. PMID: 27867992 Free PMC article. No abstract available.
Oncolytic viruses for induction of anti-tumor immunity.
Tong AW, Senzer N, Cerullo V, Templeton NS, Hemminki A, Nemunaitis J. Tong AW, et al. Among authors: senzer n. Curr Pharm Biotechnol. 2012 Jul;13(9):1750-60. doi: 10.2174/138920112800958913. Curr Pharm Biotechnol. 2012. PMID: 21740355 Review.
Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience.
Metzinger MN, Verghese C, Hamouda DM, Lenhard A, Choucair K, Senzer N, Brunicardi FC, Dworkin L, Nemunaitis J. Metzinger MN, et al. Among authors: senzer n. Oncology. 2019;97(2):59-74. doi: 10.1159/000500488. Epub 2019 Jul 1. Oncology. 2019. PMID: 31261152 Review.
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer.
Oh J, Barve M, Matthews CM, Koon EC, Heffernan TP, Fine B, Grosen E, Bergman MK, Fleming EL, DeMars LR, West L, Spitz DL, Goodman H, Hancock KC, Wallraven G, Kumar P, Bognar E, Manning L, Pappen BO, Adams N, Senzer N, Nemunaitis J. Oh J, et al. Among authors: senzer n. Gynecol Oncol. 2016 Dec;143(3):504-510. doi: 10.1016/j.ygyno.2016.09.018. Epub 2016 Sep 24. Gynecol Oncol. 2016. PMID: 27678295 Clinical Trial.
120 results